Mark Goodman is a professor in
the Department of Radiology and the director of the Radiopharmaceutical
Discovery Lab. His research centers on the radiotracer development of positron
emission tomography(PET) and single photon emission computed tomography(SPECT).
Additionally, his research helps the development of a commercialized
radiotracer, methylbranched fatty acid [123I] BMIPP (Cardiodine), in Japan.
https://winshipcancer.emory.edu/bios/faculty/goodman-mark-m.html